Form D · Biotechnology
Perspective Therapeutics, Inc.
Seattle, WA · CIK 0000728387
Offering snapshot reported Mar 18, 2024 · SEC filing
- Reported sold
- $87.4M Offering amount: $87.4M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 4, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 18, 2024 | Initial | $87,409,482 | No comparison | 9 | SEC filing |
| Jan 22, 2024 | Initial | $20,846,671 | No comparison | 1 | SEC filing |
| Feb 21, 2023 | Initial | $54,618,030 | No comparison | 54 | SEC filing |
| Jul 25, 2018 | Initial | $728,750 | No comparison | 4 | SEC filing |
| Aug 25, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 22, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 28, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 14, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 24, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 24, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $5.11M
- Finders' fees
- $0
- Form D file number
- 021-507902
Based on 92,009,981 shares of common stock at $0.95 per share.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| B. Riley Securities, Inc. | 25027 | B. Riley Securities, Inc. · CRD 25027 |
| Oppenheimer & Co. Inc. | 249 | Oppenheimer & Co. Inc. · CRD 249 |
| LifeSci Capital, LLC | 168404 | LifeSci Capital, LLC · CRD 168404 |
| JonesTrading Institutional Services LLC | 6888 | JonesTrading Institutional Services LLC · CRD 6888 |
Source: Form D, filed Mar 18, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Austin | Executive |
| William Cavanagh | Executive |
| Heidi Henson | Director |
| Alan Hoffmann | Director |
| Jonathan Hunt | Executive |
| Michael Krachon | Executive |
| Michael Mc Cormick | Director |
| Frank Morich | Director |
| Markus Puhlmann | Executive |
| Johan (Thijs) Spoor | Director, Executive |
| Jennifer Streeter | Executive |
| Philip J Vitale | Director |
| Robert Williamson Iii | Director |
| Lori Woods | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2401 Elliott Avenue Suite 320
Seattle, WA, 98121
Seattle, WA, 98121